New Zealand Datasheet Name of Medicine - Medsafe
New Zealand Datasheet Name of Medicine Ondansetron-DRLA tablets Ondansetron ODT-DRLA tablets Ondansetron hydrochloride dihydrate tablets 4 mg and 8 mg
Download New Zealand Datasheet Name of Medicine - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Ondansetron 2mg/ml Solution for Injection UK/H/1240/01/DC 2 LAY SUMMARY On 23rd July 2009, the UK granted Claris Lifesciences UK Limited a Marketing Authorisation (licences) for the medicine Ondansetron 2mg/ml Solution for Injection.
BRAND / GENERIC NAME FORMULATION PRESENTATION
www.wallacepharma.comBRAND / GENERIC NAME FORMULATION PRESENTATION Antiemetic MAXERON TABLETS Each uncoated tablet contains: 25x10's Blister Metoclopramide Tablets IP or BP Metoclopramide Hydrochloride IP / BP equivalent to 200's, 500's and
WHO Model List of Essential Medicines
www.who.int20th edition WHO Model List of Essential Medicines (March 2017) Explanatory notes The core list presents a list of minimum medicine needs for a basic health-care system, listing the most efficacious, safe and cost–effective medicines for priority conditions.
WHO Model List of Essential Medicines for Children
www.who.intWHO Model List of Essential Medicines for Children 4th list (April 2013) Status of this document This is a reprint of the text on the WHO Medicines
The Renal Drug Handbook - pharmalink.nl
www.pharmalink.nlConTEnTs vii Colchicine 184 Colestipol hydrochloride 185 Colestyramine (cholestyramine) 186 Colistin 187 Cortisone acetate 189 Co-trimoxazole (trimethoprim +